268 related articles for article (PubMed ID: 28846105)
1. C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.
Kim ES; Kim SY; Koh M; Lee HM; Kim K; Jung J; Kim HS; Moon WK; Hwang S; Moon A
Oncogene; 2018 Jan; 37(1):28-38. PubMed ID: 28846105
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression.
Kim ES; Cha Y; Ham M; Jung J; Kim SG; Hwang S; Kleemann R; Moon A
Oncogene; 2014 Jul; 33(27):3583-93. PubMed ID: 23955082
[TBL] [Abstract][Full Text] [Related]
3. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
[TBL] [Abstract][Full Text] [Related]
4. Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells.
Park HB; Golubovskaya V; Xu L; Yang X; Lee JW; Scully S; Craven RJ; Cance WG
Biochem J; 2004 Mar; 378(Pt 2):559-67. PubMed ID: 14629195
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
[TBL] [Abstract][Full Text] [Related]
6. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
7. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
[TBL] [Abstract][Full Text] [Related]
8. Receptor activator of NF-κB ligand induces cell adhesion and integrin α2 expression via NF-κB in head and neck cancers.
Yamada T; Tsuda M; Wagatsuma T; Fujioka Y; Fujioka M; Satoh AO; Horiuchi K; Nishide S; Nanbo A; Totsuka Y; Haga H; Tanaka S; Shindoh M; Ohba Y
Sci Rep; 2016 Mar; 6():23545. PubMed ID: 27009236
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
11. Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer.
Van Slambrouck S; Jenkins AR; Romero AE; Steelant WF
Int J Oncol; 2009 Jun; 34(6):1717-26. PubMed ID: 19424590
[TBL] [Abstract][Full Text] [Related]
12. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
13. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
15. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
16. H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2.
Park S; Kim ES; Noh DY; Hwang KT; Moon A
Cytokine; 2011 Jul; 55(1):126-33. PubMed ID: 21524920
[TBL] [Abstract][Full Text] [Related]
17. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
[TBL] [Abstract][Full Text] [Related]
18. Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.
Sundgren NC; Zhu W; Yuhanna IS; Chambliss KL; Ahmed M; Tanigaki K; Umetani M; Mineo C; Shaul PW
Circ Res; 2011 Oct; 109(10):1132-40. PubMed ID: 21940940
[TBL] [Abstract][Full Text] [Related]
19. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
